WHO ICTRP trial
CONTACT: A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled…
EUCTR2009-011799-31-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-011799-31-GB |
|---|---|
| Public title | CONTACT: A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Six-Month Safety and Efficacy Study of Dimebon in Patients with Moderate-to-Severe Alzheimer’s Disease and Neuropsychiatric Symptoms - CONTACT |
| Scientific title | CONTACT: A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Six-Month Safety and Efficacy Study of Dimebon in Patients with Moderate-to-Severe Alzheimer’s Disease and Neuropsychiatric Symptoms - CONTACT |
| Primary sponsor | Medivation, Inc |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Portugal;United Kingdom;Spain;Ireland;Italy;Portugal;United Kingdom;Spain;Ireland;Italy |
| Conditions | Alzheimer's disease MedDRA version: 9.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease ;Alzheimer's disease MedDRA version: 9.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease |
| Interventions | Product Name: Dimebon Product Code: Dimebon Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Dimebon dihydrochloride CAS Number: 97657-92-6 Current Sponsor code: Dimebon Other descriptive name: Dimebon dihydrochloride… |
| Registration date | Jun 26, 2009 |
| Target size | 600 |
| Secondary IDs | DIM19;DIM19 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: